0001387131-14-004164.txt : 20141229 0001387131-14-004164.hdr.sgml : 20141225 20141229163213 ACCESSION NUMBER: 0001387131-14-004164 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141229 DATE AS OF CHANGE: 20141229 EFFECTIVENESS DATE: 20141229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-230984 FILM NUMBER: 141313056 BUSINESS ADDRESS: STREET 1: 1245 BRICKYARD RD STREET 2: #590 CITY: SALT LAKE CITY, STATE: UT ZIP: 84106 BUSINESS PHONE: 347-753-4389 MAIL ADDRESS: STREET 1: 1245 BRICKYARD RD STREET 2: #590 CITY: SALT LAKE CITY, STATE: UT ZIP: 84106 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 D 1 primary_doc.xml X0707 D LIVE 0001173281 Ohr Pharmaceutical Inc 800 THIRD AVENUE 11TH FLOOR NEW YORK NY NEW YORK 10022 212-682-8452 DELAWARE None BBM HOLDINGS, INC. PRIME RESOURCE INC Corporation true Ira Greenstein c/o Ohr Pharmaceutical, Inc. 800 Third Avenue, 11th Floor New York NY NEW YORK 10022 Director Irach Taraporewala c/o Ohr Pharmaceutical, Inc. 800 Third Avenue, 11th Floor New York NY NEW YORK 10022 Executive Officer Director Orin Hirschman c/o Ohr Pharmaceutical, Inc. 800 Third Avenue, 11th Floor New York NY NEW YORK 10022 Director Thomas Riedhammer c/o Ohr Pharmaceutical, Inc. 800 Third Avenue, 11th Floor New York NY NEW YORK 10022 Director June Almenoff c/o Ohr Pharmaceutical, Inc. 800 Third Avenue, 11th Floor New York NY NEW YORK 10022 Director Sam Backenroth c/o Ohr Pharmaceutical, Inc. 800 Third Avenue, 11th Floor New York NY NEW YORK 10022 Executive Officer Biotechnology No Revenues 06b false 2014-12-24 false true false 0 50000 50000 0 The Company issued common stock equal to $50,000 to its outside counsel in settlement of legal fees. false 1 0 0 0 false Ohr Pharmaceutical Inc /s/ Sam Backenroth Sam Backenroth Chief Financial Officer 2014-12-29